Global Malaria Vaccines Market Research Report 2020

SKU ID : QYR-15164260 | Publishing Date : 05-Feb-2020 | No. of pages : 98

Malaria Vaccines are used for malaria treatment.Malaria is a severe and widespread disease caused by a parasitic infection by protozoan Plasmodium when transmitted by various species of anopheles mosquitoes.
The growing incidence of malaria globally and major players pledging for low profit margin over vaccines is expected to boost growth of the market for malaria vaccines market.

The global Malaria Vaccines market is valued at 13 million US$ in 2020 is expected to reach 35 million US$ by the end of 2026, growing at a CAGR of 15.1% during 2021-2026.
This report focuses on Malaria Vaccines volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Malaria Vaccines market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan etc.
Market Segment Analysis
The research report includes specific segments by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type, the Malaria Vaccines market is segmented into
Pre-Erythrocytic Vaccine
Erythrocytic Vaccine
Multi-antigen Vaccine

Segment by Application
Hospitals
Clinics
Community Centers

Global Malaria Vaccines Market: Regional Analysis
The Malaria Vaccines market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026.
The key regions covered in the Malaria Vaccines market report are:
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Global Malaria Vaccines Market: Competitive Analysis
This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.
The major players in global Malaria Vaccines market include:
GlaxoSmithKline plc
Sanaria Inc
Nobelpharma Co
Sumaya Biotech
GenVec

Frequently Asked Questions

This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
  • By product type
  • By End User/Applications
  • By Technology
  • By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
market Reports market Reports